Our vision

Gerot Lannach was formed out of a merger of the two pharmaceutical companies Gerot and Lannacher and has a history of more than 70 years.

We develop, produce and marekt unique brand name products as well as off-patent products for the wellbeing of people in Austria and abroad. As a supplier to the healthcare sector, we partner with general practitioners, pharmacists, their patients and pharmaceutical wholesalers. As an international player, we market our products through our licensees and branch offices in more than 50 countries.

Our core competence concentrates on three different business areas:

  • Cardiovascular system
  • Central nervous system
  • Urology, oncology and opioid substitution therapy
Martin Bartenstein
CEO
Ilse Bartenstein
CEO
    Martin Bartenstein
    CEO
    Ilse Bartenstein
    CEO
1947/48
Foundation of Lannacher Heilmittel in Lannach/Graz and Gerot Pharmazeutika in Vienna
1966
Leopold and Hannelore Bartenstein take over Lannacher Heilmittel
1997
Lannacher Heilmittel acquires Gerot Pharmazeutika
2003
Start of operation in the state-of-the-art solid forms production site Lannach
2009
Lannacher and Gerot merge under the brand Gerot Lannach in G.L. Pharma
2012
Strategic partnership with Bausch Health in Russia and CIS markets
    1947/48
    Foundation of Lannacher Heilmittel in Lannach/Graz and Gerot Pharmazeutika in Vienna
    1966
    Leopold and Hannelore Bartenstein take over Lannacher Heilmittel
    1997
    Lannacher Heilmittel acquires Gerot Pharmazeutika
    2003
    Start of operation in the state-of-the-art solid forms production site Lannach
    2009
    Lannacher and Gerot merge under the brand Gerot Lannach in G.L. Pharma
    2012
    Strategic partnership with Bausch Health in Russia and CIS markets
Facts & Figures

Markets
Our products can be found in more than 50 markets worldwide. Gerot Lannach has 16 distribution structures in Europe and a subsidiary in Central America.

Headcount
~1.000 employees

Revenues
~€200 M. (2020), revenue including Genericon Pharma €300 M. (2020)

Production Volume
~4.400 M. single doses

 
Facts & Figures

Markets
Our products can be found in more than 50 markets worldwide. Gerot Lannach has 16 distribution structures in Europe and a subsidiary in Central America.

Headcount
~1.000 employees

Revenues
~€200 M. (2020), revenue including Genericon Pharma €300 M. (2020)

Production Volume
~4.400 M. single doses

Transparency

In healthcare, trust is required.

Gerot Lannach works closely with physicians, other healthcare professionals and medical facilities to provide an optimum patient care.
As a responsible company, Gerot Lannach is committed to transparency.

Within the EFPIA Transparency Code, we disclose financial contributions to healthcare professionals.